& Schweizer, A
Statistics and reproducibility The phase 2 clinical trial was powered to show a difference in proportions of 28% on primary endpoint MASH resolution and no worsening of fibrosis between once-daily semaglutide 0.4 mg (assumed 45% response) and placebo (assumed 17% response)
Grriz JL, Soler MJ, Navarro-Gonzlez JF, Garca-Carro C, Puchades MJ, D'Marco L, et al
The findings identify an FXR/PXR-driven cross-talk pathway that links lipid and amino-acid metabolism and provide a mechanistic rationale for BBBP in NASH therapy (Jiang et al., 2023)
These findings warrant further research evaluation of GHK-Cu in the context of wound care
The primary function of glutathione is to combat oxidative stress, which can damage cells and lead to various health issues, including skin problems